Literature DB >> 7766095

Tissue engineering of a bioartificial pancreas: modeling the cell environment and device function.

E Tziampazis1, A Sambanis.   

Abstract

Cell-based implantable artificial tissues are most promising for the long-term treatment of endocrine diseases, such as diabetes. One type of a bioartificial pancreas device consists of calcium alginate microbeads containing insulin-secreting cells and is surrounded by a poly(L-lysine) (PLL) membrane. The membrane is semipermeable, allowing cellular nutrients and metabolites to diffuse through but excluding the antibodies and cytotoxic cells of the host, thus immunoprotecting the cells. The device can be modeled by writing the equations for diffusion of nutrients and metabolites through the polymer and for consumption of the former and production of the latter by the cells. In this paper, we describe the construction and analysis of such a model for alginate/PLL microbeads with insulin-secreting recombinant mouse pituitary AtT-20 and mouse insulinoma beta TC3 cells. Entrapped AtT-20 cells are a simplified model system, whereas microbeads with beta TC3 cells constitute a realistic artificial pancreatic device. Effective diffusivities of key compounds through the polymer with entrapped, inactivated AtT-20 spheroids were measured first. The kinetics of glucose and oxygen consumption and insulin secretion were modeled next, and the equations for diffusion and reaction were then combined to describe the entire system. The model was used to compute nutrient and metabolite concentration profiles in beads and the bead secretory response for different bead sizes and cell loadings. The size and loading necessary for the cells to be well nourished and for the beads to be rapidly responsive to step-ups and step-downs of secretion stimuli were evaluated. It was shown that if the cells are hypersensitive to glucose, i.e., they do not shut off secretion at the physiological glucose threshold but at a lower one, so are the microbeads. This work demonstrates the usefulness of mechanistic models with representative parameter values in optimizing the design of artificial tissues and in characterizing aspects of their behavior that are of importance for restoring in vivo function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766095     DOI: 10.1021/bp00032a001

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  15 in total

1.  Association between macrophage activation and function of micro-encapsulated rat islets.

Authors:  P de Vos; I Smedema; H van Goor; H Moes; J van Zanten; S Netters; L F M de Leij; A de Haan; B J de Haan
Journal:  Diabetologia       Date:  2003-05-15       Impact factor: 10.122

2.  Modeling of encapsulated cell systems.

Authors:  Jeffrey D Gross; I Constantinidis; A Sambanis
Journal:  J Theor Biol       Date:  2006-08-26       Impact factor: 2.691

Review 3.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

4.  Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing.

Authors:  Aaron L Glieberman; Benjamin D Pope; John F Zimmerman; Qihan Liu; John P Ferrier; Jennifer H R Kenty; Adrian M Schrell; Nikita Mukhitov; Kevin L Shores; Adrian Buganza Tepole; Douglas A Melton; Michael G Roper; Kevin Kit Parker
Journal:  Lab Chip       Date:  2019-09-10       Impact factor: 6.799

5.  Therapeutic effects of a non-β cell bioartificial pancreas in diabetic mice.

Authors:  Aubrey R Tiernan; Peter M Thulé; Athanassios Sambanis
Journal:  Transplantation       Date:  2014-09-15       Impact factor: 4.939

6.  Limited beneficial effects of perfluorocarbon emulsions on encapsulated cells in culture: experimental and modeling studies.

Authors:  Fernie Goh; Jeffrey D Gross; Nicholas E Simpson; Athanassios Sambanis
Journal:  J Biotechnol       Date:  2010-09-08       Impact factor: 3.307

7.  Glucose-stimulated insulin release: Parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets.

Authors:  Peter Buchwald; Alejandro Tamayo-Garcia; Vita Manzoli; Alice A Tomei; Cherie L Stabler
Journal:  Biotechnol Bioeng       Date:  2017-09-19       Impact factor: 4.530

8.  Towards the development of a bioartificial pancreas: immunoisolation and NMR monitoring of mouse insulinomas.

Authors:  A Sambanis; K K Papas; P C Flanders; R C Long; H Kang; I Constantinidis
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

9.  Cryoprotectant delivery and removal from murine insulinomas at vitrification-relevant concentrations.

Authors:  Indra Neil Mukherjee; Ying C Song; Athanassios Sambanis
Journal:  Cryobiology       Date:  2007-04-10       Impact factor: 2.487

10.  Insulin secretion dynamics of free and alginate-encapsulated insulinoma cells.

Authors:  Shing-Yi Cheng; Ioannis Constantinidis; Athanassios Sambanis
Journal:  Cytotechnology       Date:  2006-11-16       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.